LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inverness Medical Acquires Benelux Distributor Orange Medical

By Labmedica staff writers
Posted on 15 May 2007
Inverness Medical Innovations, Inc. (Waltham, MA, USA), a manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, has acquired Benelux distributor Orange Medical (Tilburg, The Netherlands) in an all cash deal for approximately €4.2 million, or US$5.7 million.

The acquisition of Orange Medical, which has companies in the Netherlands and Belgium, will increase Inverness' direct distribution network for its professional diagnostic products into Benelux. The acquisition is consistent with Inverness' efforts to continue to improve margins by bringing distribution in-house.

Inverness Medical Innovations is a developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno-diagnostics with a focus on women's health, cardiology, and infectious disease.

Orange Medical is an independent company active the Benelux (Belgium, Netherlands, Luxemburg) and serving hospitals and laboratories in the health care sector. Its selling and marketing activities are focused in the following market segments: immunodiagnostics, reproduction, and fertility prenatal diagnostics point-of-care (POC).


Related Links:
Inverness Medical Innovations
Orange medical

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Manual Pipetting Aid
Pipette Controllers macro
Urine Analyzer
respons® UDS100

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
15 May 2007  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
15 May 2007  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
15 May 2007  |   Industry